The company was formed by Scott D. Boden, MD, chief medical officer of Emory University Orthopaedic & Spine Hospital and professor of orthopedics at Emory University, and Stephen R. LaNeve, former president of a spinal and biologics division of a global medical device company. SkelRegen will focus on developing technologies for skeletal tissue formation.
More Articles on Orthopedic Devices:
37 Orthopedic & Spine Devices Receives FDA 510(k) Clearance in September
